secwatch.observer — SEC 8-K summary
======================================

Issuer:     UTAH MEDICAL PRODUCTS INC (UTMD)
CIK:        0000706698
Form:       8-K
Filed at:   2021-10-26T23:59:59+00:00
Accession:  0001096906-21-002587
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01, 99.1
LLM model:  deepseek-v4-flash:cloud@v2

UTMD Q3 2021 EPS $1.150, revenue up 20%; 9M non-GAAP EPS $3.021, up 46%
-----------------------------------------------------------------------

- Q3 2021 net income $4.2M (33.5% of sales), up 43.4% YoY; diluted EPS $1.150.
- 9M 2021 US GAAP net income $10.7M, up 44.3%; non-GAAP net income $11.0M, up 45.1%.
- Cash and investments at Sep 30, 2021: $64.3M, up from $51.6M at Dec 31, 2020.
- Management expects FY2021 adjusted EBITDA >$26M ($28M for 2022).
- Dividend increased to $0.285/share; total 9M dividends $3.1M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/706698/000109690621002587/0001096906-21-002587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/706698/000109690621002587/utmd-20211026.htm
  HTML page:      https://secwatch.observer/filing/0001096906-21-002587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer